Total Payments
$63,910
2024 Payments
$1,541
Companies
73
Transactions
1,131
Medicare Patients
14,969
Medicare Billing
$4.0M
Payment Breakdown by Category
Other$38,725 (60.6%)
Food & Beverage$19,956 (31.2%)
Travel$3,951 (6.2%)
Consulting$1,223 (1.9%)
Education$55.58 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,725 | 19 | 60.6% |
| Food and Beverage | $19,956 | 1,090 | 31.2% |
| Travel and Lodging | $3,951 | 16 | 6.2% |
| Consulting Fee | $1,223 | 1 | 1.9% |
| Education | $55.58 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Depomed, Inc. | $27,613 | 63 | $0 (2017) |
| Boston Scientific Corporation | $17,407 | 102 | $0 (2024) |
| Abbott Laboratories | $6,410 | 325 | $0 (2024) |
| Vertiflex, Inc. | $2,154 | 11 | $0 (2019) |
| INSYS Therapeutics Inc | $1,397 | 18 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,166 | 107 | $0 (2024) |
| ABBVIE INC. | $951.29 | 60 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $896.09 | 99 | $0 (2024) |
| Amgen Inc. | $393.99 | 21 | $0 (2022) |
| Daiichi Sankyo Inc. | $367.11 | 29 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,541 | 81 | Abbott Laboratories ($375.82) |
| 2023 | $2,064 | 149 | Abbott Laboratories ($647.72) |
| 2022 | $2,326 | 165 | Abbott Laboratories ($1,084) |
| 2021 | $2,162 | 133 | Abbott Laboratories ($1,002) |
| 2020 | $2,373 | 105 | Abbott Laboratories ($1,283) |
| 2019 | $4,191 | 94 | Vertiflex, Inc. ($2,154) |
| 2018 | $12,078 | 159 | Boston Scientific Corporation ($10,071) |
| 2017 | $37,175 | 245 | Depomed, Inc. ($27,613) |
All Payment Transactions
1,131 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $5.90 | General |
| Category: Opioid Analgesic | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $31.95 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $95.21 | General |
| Category: General - Therapies_NMD | ||||||
| 11/06/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.99 | General |
| Category: Opioid Analgesic | ||||||
| 10/29/2024 | Abbott Laboratories | PRODIGY (Device) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: Neuromodulation | ||||||
| 10/28/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/28/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.04 | General |
| Category: Opioid Analgesic | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.32 | General |
| Category: Opioid Analgesic | ||||||
| 10/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| Category: Opioid Analgesic | ||||||
| 09/11/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $45.40 | General |
| Category: Pain Management | ||||||
| 09/05/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $36.09 | General |
| Category: Central Nervous System | ||||||
| 09/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Neuromodulation | ||||||
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.64 | General |
| Category: Opioid Analgesic | ||||||
| 08/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/16/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: Opioid Analgesic | ||||||
| 08/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 3,928 | 16,316 | $2.8M | $1.2M |
| 2022 | 41 | 4,056 | 18,318 | $2.0M | $789,430 |
| 2021 | 47 | 3,932 | 43,520 | $3.1M | $1.3M |
| 2020 | 44 | 3,053 | 19,326 | $2.5M | $819,218 |
Total Patients
14,969
Total Services
97,480
Medicare Billing
$4.0M
Procedure Codes
212
All Medicare Procedures & Services
212 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 567 | 1,916 | $852,620 | $456,439 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 555 | 3,049 | $640,155 | $282,061 | 44.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 449 | 2,944 | $235,569 | $139,429 | 59.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 528 | 1,382 | $221,120 | $83,229 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 160 | 446 | $62,440 | $25,940 | 41.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 45 | 64 | $34,310 | $14,842 | 43.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 46 | 64 | $78,284 | $10,648 | 13.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 64 | 97 | $77,222 | $10,230 | 13.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 18 | 26 | $21,320 | $9,871 | 46.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 30 | 37 | $18,500 | $6,750 | 36.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 27 | 32 | $16,320 | $6,276 | 38.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $16,640 | $6,050 | 36.4% |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 2023 | 11 | 825 | $157,500 | $5,876 | 3.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 69 | 119 | $15,470 | $5,709 | 36.9% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 12 | 15 | $12,450 | $5,371 | 43.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 25 | 54 | $10,445 | $5,315 | 50.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 18 | 25 | $8,681 | $5,220 | 60.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 33 | 49 | $38,208 | $5,095 | 13.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 14 | 23 | $11,162 | $4,322 | 38.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 46 | 65 | $14,169 | $3,700 | 26.1% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 16 | 22 | $24,976 | $3,580 | 14.3% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 30 | 31 | $8,680 | $3,521 | 40.6% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 29 | 39 | $23,115 | $3,417 | 14.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 58 | 92 | $8,280 | $3,411 | 41.2% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 46 | 64 | $28,020 | $3,309 | 11.8% |
About Dr. Nikesh Seth, MD
Dr. Nikesh Seth, MD is a Pain Medicine healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2010. The National Provider Identifier (NPI) number assigned to this provider is 1922327030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nikesh Seth, MD has received a total of $63,910 in payments from pharmaceutical and medical device companies, with $1,541 received in 2024. These payments were reported across 1,131 transactions from 73 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,725).
As a Medicare-enrolled provider, Seth has provided services to 14,969 Medicare beneficiaries, totaling 97,480 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 212 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location Scottsdale, AZ
- Active Since 05/28/2010
- Last Updated 04/25/2019
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1922327030
Products in Payments
- Nucynta (Drug) $18,956
- GENERAL PAIN MANAGEMENT (Device) $7,348
- Gralise (Drug) $4,528
- GENERAL - PAIN MANAGEMENT (Device) $4,296
- Lazanda (Drug) $4,147
- PRECISION (Device) $2,472
- Superion ISS (Device) $2,154
- Proclaim Family of SCS IPGs (Device) $1,933
- PROCLAIM (Device) $1,711
- SUBSYS (Drug) $1,397
- RELISTOR (Drug) $1,024
- THERAPIES (Device) $1,008
- Proclaim IPG (Device) $794.11
- SPECTRA WAVEWRITER (Device) $706.08
- XTAMPZA (Drug) $654.86
- BOTOX (Biological) $629.89
- SCS IPGs (Device) $547.77
- UBRELVY (Drug) $451.56
- INFINION (Device) $451.14
- Neuromodulation Dspsbls and Accs (Device) $402.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Scottsdale
Dr. Tory Mcjunkin, M.d, M.D
Pain Medicine — Payments: $293,715
Pain Medicine $293,715
Vivek Iyer, M.d, M.D
Pain Medicine — Payments: $70,453
Pain Medicine $70,453
Dr. Steve Fanto, Md, MD
Pain Medicine — Payments: $43,057
Pain Medicine $43,057
Dr. Matthew Crooks, Md, MD
Pain Medicine — Payments: $20,391
Pain Medicine $20,391
Natalie Strand, M.d, M.D
Pain Medicine — Payments: $19,142
Pain Medicine $19,142
Dr. Ashu Goyle, Do, DO
Pain Medicine — Payments: $12,755
Pain Medicine $12,755